Join us for a special edition of Science Says on Tuesday, November 30. Trevor Noah, comedian and host of "The Daily Show," will chat with three Hutch researchers who are fearlessly working to end cancer and COVID-19.
Trevor Noah is the most successful comedian in Africa and is the host of the Emmy® Award-winning "The Daily Show" on Comedy Central. "The Daily Show with Trevor Noah" has received numerous Emmy Award nominations, including Outstanding Variety Talk Series and Outstanding Writing for a Variety Series. Trevor is also the author of the #1 New York Times bestseller "Born a Crime: Stories from a South African Childhood," which has received the Thurber Prize for American Humor and two NAACP Image Awards.
Dr. Thomas J. Lynch Jr., Fred Hutch president and director, is a lung cancer physician and scientist known around the world for his pioneering role in precision medicine. He joined the Hutch just weeks before the pandemic began and has guided the organization's response with urgency, compassion, and a commitment to sparking scientific solutions — all while advancing the cancer research at the heart of its mission. He holds the Raisbeck Endowed Chair.
Dr. Trevor Bedford was named a Howard Hughes Medical Institute Investigator and a MacArthur Fellow, also known as the MacArthur "genius grant," for his research and public health contributions in tracking the spread and evolution of viruses, particularly SARS-CoV-2, which causes COVID-19. Trevor uses powerful computers, complex statistical methods, and the software tool he co-developed, Nextstrain, to study a range of viral outbreaks, including influenza, Ebola, and Zika.
Dr. Phil Greenberg is a pioneer in the field of cancer immunotherapy, a form of treatment that aims to harness the power of the immune system to eliminate cancer. Nicknamed Dr. T-Cell, his early discoveries showed how to target diseases with immune T cells and helped drive a burgeoning field. Phil's team continues to develop and test strategies to genetically reprogram a patient's T cells to more effectively target cancers, including solid tumors. He holds The Rona Jaffe Foundation Endowed Chair.
Dr. Rachel Issaka is a gastroenterologist and clinical researcher who has gained national recognition for her work to prevent colorectal cancer deaths — and increase health equity — by developing novel ways to reach, screen, and ensure follow-up for at-risk individuals. She is also a leading voice on dismantling racism in the medical field. Rachel serves as a colorectal cancer advisor to the President's Cancer Panel and was included in Puget Sound Business Journal's 2021 list of "40 under 40" Seattle-area leaders.